Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetic Foot Ulcer01:31

Diabetic Foot Ulcer

Definition A diabetic foot ulcer (DFU) is a chronic, non-healing wound that develops in individuals with diabetes. It typically occurs on pressure-bearing areas such as the heel, metatarsal heads, or hallux, and carries a high risk of infection and amputation.Pathophysiology • The development of DFUs can be explained by four interconnected mechanisms: neuropathy, ischemia, infection, and impaired wound healing. • Neuropathy is the most common factor. Sensory neuropathy reduces pain perception,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Healing II: Complications01:24

Healing II: Complications

Complications during healing arise when tissue repair is altered by local or systemic factors. These changes involve abnormal collagen deposition, altered biomechanics, and reduced vascular supply, impairing restoration of normal structure and function.Loss of FunctionScar tissue differs significantly from the original tissue it replaces. In the skin, fibrosis lacks adnexal structures such as hair follicles, sebaceous glands, and sweat glands. Their absence reduces tactile sensitivity, impairs...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Elevated IL-4 and IL-13 Expression in Hailey-Hailey Disease: Evidence for Th2-Mediated Pathogenesis and Targeted Treatment.

Journal of cutaneous pathology·2026
Same author

Histopathologic Spectrum of Scleromyxedema: Classic and Granulomatous Patterns With Emphasis on Eosinophilic Infiltrates and Eccrine Gland Proliferation as Diagnostic Masqueraders.

The American Journal of dermatopathology·2026
Same author

Aryl Hydrocarbon Receptor Expression in Cutaneous Lupus: A Clinicopathologic Correlation.

The American Journal of dermatopathology·2026
Same author

Vascular Proliferation in Biopsies from Active Lichen Planopilaris as a Novel Pathologic Finding.

The American Journal of dermatopathology·2026
Same author

Comorbidity Burden and Biologic Access in an Uninsured Psoriasis Population: A 20-Year Descriptive Study.

International journal of dermatology·2026
Same author

Equitable access to biologic therapies in a psoriasis safety-net clinic: A retrospective cohort study.

Clinics in dermatology·2025

Related Experiment Video

Updated: Jul 2, 2026

Protocol to Create Chronic Wounds in Diabetic Mice
06:55

Protocol to Create Chronic Wounds in Diabetic Mice

Published on: September 25, 2019

Hyperhomocysteinemia and lower extremity wounds.

Elissa M Schwartzfarb1, Paolo Romanelli

  • 1Department of Dermatology and Cutaneus Surgery, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.

The International Journal of Lower Extremity Wounds
|September 2, 2008
PubMed
Summary

Elevated homocysteine levels may indicate a risk for chronic lower limb wounds. This review explores homocysteine metabolism, vascular injury, and potential treatments for these debilitating conditions.

Related Experiment Videos

Last Updated: Jul 2, 2026

Protocol to Create Chronic Wounds in Diabetic Mice
06:55

Protocol to Create Chronic Wounds in Diabetic Mice

Published on: September 25, 2019

Area of Science:

  • Vascular Medicine
  • Metabolic Disorders
  • Wound Healing Research

Background:

  • Chronic lower extremity wounds, including leg and foot ulcers, stem from conditions like venous insufficiency, arterial disease, and diabetes.
  • Hyperhomocysteinemia, an elevation in homocysteine levels, has been recognized for over 30 years as an independent risk factor for thrombosis, atherosclerosis, and cardiovascular disease.

Purpose of the Study:

  • To review the metabolism of homocysteine.
  • To examine the mechanisms of vascular injury associated with elevated homocysteine.
  • To investigate the potential role of hyperhomocysteinemia as a marker for chronic lower limb ulceration and discuss treatment strategies.

Main Methods:

  • Literature review focusing on homocysteine metabolism and vascular pathology.
  • Analysis of existing evidence linking hyperhomocysteinemia to cardiovascular and thrombotic events.
  • Exploration of studies investigating homocysteine levels in patients with chronic lower extremity wounds.

Main Results:

  • Hyperhomocysteinemia is a significant risk factor for venous and arterial thrombosis and atherosclerosis.
  • While a direct cause-effect relationship is not fully established, elevated homocysteine levels are suggested to be a marker for chronic lower limb ulceration.
  • Understanding homocysteine metabolism and vascular injury mechanisms is crucial.

Conclusions:

  • Hyperhomocysteinemia may serve as a potential biomarker for chronic lower extremity wounds.
  • Further research is warranted to elucidate the precise role of homocysteine in wound pathogenesis.
  • Exploring homocysteine-lowering therapies could offer new treatment avenues for patients with chronic lower limb ulceration.